A detailed history of Sierra Summit Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sierra Summit Advisors LLC holds 6,940 shares of MRK stock, worth $691,918. This represents 0.18% of its overall portfolio holdings.

Number of Shares
6,940
Previous 6,970 0.43%
Holding current value
$691,918
Previous $863 Million 8.67%
% of portfolio
0.18%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $3,334 - $3,869
-30 Reduced 0.43%
6,940 $788 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $108,572 - $116,605
877 Added 14.39%
6,970 $863 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $39,520 - $46,050
349 Added 6.08%
6,093 $804 Million
Q4 2023

Feb 22, 2024

BUY
$100.18 - $109.02 $575,433 - $626,210
5,744 New
5,744 $626 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sierra Summit Advisors LLC Portfolio

Follow Sierra Summit Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sierra Summit Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sierra Summit Advisors LLC with notifications on news.